Introduction This paper aims to assess the diagnostic accuracy of an 11C-choline positron emission tomography/computed tomography (PET/CT) scan in the detection of lymph node (LN) metastases in patients with biochemical recurrence after radically treated prostate cancer (PCa), as compared to histology. The secondary goal is to depict spreading patterns of metastatic LNs in recurrent PCa. Material and methods A single center retrospective study comprising of 30 patients who underwent retroperitoneal and/or pelvic salvage lymph node dissection (LND) due to 11C-choline PET/CT-positive nodal recurrences after radical treatment (median Prostate Specific Antigen (PSA) 1.5 ng/ml, range 0.2-11.4). Positive nodes on the preoperative PET/CT scans were mapped and compared to post-operative pathology results. LNs were marked as true positive, false positive, true negative and false negative and a patient-and a region-based analysis was performed. Sensitivity, specificity and positive/negative predictive value (PPV/NPV) were calculated. Results Sixty positive LNs were detected on PET/CT with a median number of two positive nodes per patient (range 1-6). In 29 patients, a super-extended pelvic LND (PLND) was performed combined with a retroperitoneal LND (RPLND) in 13 of those cases. One patient underwent an inguinal LND. One hundred thirty-seven of 644 resected LNs contained metastases. The 11C-choline PET/CT scan correctly predicted 31 positive nodes (55%) while 25 nodes were falsely positive (45%). One hundred and six histologically proven metastatic nodes were not detected on the 11C-choline PET/CT scan (77%). Sensitivity, specificity, PPV and NPV of the 11C-choline PET/CT were 23%, 95%, 55% and 82%, respectively. Conclusions 11C-choline PET/CT has a relatively low detection rate and a moderate PPV for metastatic LNs in patients with biochemical recurrence after radically treated PCa. Key Words: 11C-choline PET/CT ‹› biochemical recurrence ‹› prostate cancer ‹› salvage lymphadenectomy Citation: Deconinck S, Tosco L, Merckx L, et al. Anatomical mapping of lymph nodes in patients receiving salvage lymphadenectomy based on a positive 11c-choline positron emission tomography/computed tomography (PET/CT) scan. Cent European J Urol. 2019; 72: 232-239.
mary treatment with RP, EBRT, brachytherapy (BT) or high intensity focused ultrasound (HIFU) and with evidence of nodal 11C-choline PET/CT-positivity were considered for inclusion. PSA relapse was defined as two consecutive rises of PSA greater than 0.2 ng/ml after RP or three consecutive rises of PSA above the nadir after EBRT, BT or HIFU [13, 14] . Patients with one to a maximum of six positive lesions on an 11C-choline PET/CT scan were eligible for salvage LND. Patients with symptomatic metastases, inoperable disease or previous treatment with cytotoxic agents for PCa were excluded. Thirty patients with inclusion criteria provided consent for surgery and for data collection for scientific publication. Eight of them were on androgen deprivation therapy (ADT) at the moment of the PET by / CT. Detailed patient characteristics are reported in Table 1 . The local ethical review board approved the study.
11C-choline PET/CT
11C-choline PET/CT images were acquired using a Siemens Biograph Hirez 16-slice or TruePoint 40-slice PET/CT system (Siemens Medical, Erlangen, Germany) after at least 6 hours of fasting, as previously described [15] . Immediately after injection of 740 to 1000 MBq of 11C-choline, a contrast-enhanced CT scan was performed with 120 ml of a non-ionic contrast agent injected intravenously (Ultravist, Schering), followed by the 11C-choline PET-emission scan. PET data were acquired in six bed positions with a 5 minute scanning time per bed position, starting from the pelvis at approximately 4 minutes after injection. Images were iteratively reconstructed using Ordered Subsets Expectation Maximization (5 iterations and 8 subsets) with an isotropic Gaussian postreconstruction smoothing of 6 mm. Attenuation correction was performed using CT. All scans were retrospectively analyzed by an experienced nuclear medicine specialist (K.E.G.), who was blinded from all other data, using Hermes Hybrid Viewer (Hermes Medical Solutions, Stockholm, Sweden). Sites of pathological 11C-choline uptake were compared with background activity and were assigned to a LN region based on the overlaid CT images.
INTRODUCTION
Radical treatments such as radical prostatectomy (RP) and external beam radiotherapy (EBRT) are well-established therapeutic options in the management of localized prostate cancer (PCa). Despite all of the technical improvements, 20-30% of patients after RP [1] and 30-40% of men after EBRT [2, 3] will experience recurrence. PCa recurrence can be local, in regional pelvic lymph node metastases (LNM) or in distant metastases (distant LNM, bone or soft tissue metastases). Local PCa recurrence can be treated by salvage radiotherapy (RT) of the prostate fossa with good results [4] . In contrast, a rise in prostate specific antigen (PSA) in patients without recurrence in the prostatic fossa, often points to (micro) metastatic disease making its treatment challenging. Salvage lymph node dissection (LND) has recently been brought forward as an option in the treatment of oligometastatic PCa with up to 40% of men being without clinical recurrence after a median followup of 81 months [5, 6] . Therefore, accurate imaging to assess the extent and localization of the relapse is of great importance and has been the subject of many research projects. The European Association of Urology (EAU) guidelines acknowledge the low diagnostic yield of bone scan and abdominopelvic CT [7] . Before the introduction of the Prostate-Specific Membrane Antigen-based (PSMA) PET/CT, 11Ccholine [8] and 18F-fluorocholine [9] PET/CT were considered to be amongst the most accurate tools available for detection of metastatic lesions in patients with biochemical recurrence [4] . However, the level of evidence remains limited since many of the supporting studies are retrospective, explorative and without pathological verification. Moreover, resection templates are often limited and targeted on the PET-positive lesions [2, 10, 11, 12] . We performed a histology verified retrospective analysis comparing the preoperative 11C-choline PET/CT with histology in patients after salvage LND for PSA relapse after treatment with curative intention. Furthermore, all resected lymph nodes (LNs) were anatomically mapped in an attempt to depict the spreading patterns of metastatic LNs in recurrent PCa.
MATERIAL AND METHODS

Patients
Medical records of all patients who underwent salvage LND at our institution between December 2011 and December 2014 were reviewed retrospectively. Patients with biochemically recurrent PCa after pri-without PLND. During surgery, a super-extended (se) PLND was always attempted, as previously described [16] . RPLND was performed if positive nodes were seen in the retroperitoneal lymph node regions. The following anatomic regions were used to locate the nodes on the 11C-choline PET/CT scan as well as for the surgical resection template as previously described [17] : para-aortic, paracaval, preaortic, precaval, interaortocaval, common iliac, external iliac, obturator fossa, internal iliac, presacral, pararectal, inguinal. All dissected nodes were sent to pathology in separate containers according to the region of dissection. In four cases, adjacent regions were dissected en bloc and sent together for histological evaluation. Histopathological data were compared with the results of the preoperative 11C-choline PET/CT scans in a per-region analysis. Four nodes were positive on the a posteriori revision of the PET scans without pathology available for analysis. All LNs were mapped on a vascular map according to their status.
Histopathology
All specimens were delivered in separate boxes labeled according to the anatomical area. In four patients the specimen of a few adjacent regions was sent en bloc. LNs were fixed in 6% formalin. All stations were examined by visual inspection, palpation and sectioning. Each identified LN was cut in two before paraffin embedding. From these blocks, one 5 µm section was cut per LN. The pathologist microscopically evaluated the presence of metastases in each section after staining with hematoxylin and eosin.
Statistics
A comparison of the different proportions was performed by the Chi square test or Fisher's exact test. Sensitivity and specificity, as well as positive and negative predictive (PPV/NPV) value were calculated according to their standard definitions. All significance levels were set at 0.05 (MedCalc Software, Mariakerke, Belgium).
RESULTS
11C-choline PET/CT detected 60 suspicious LNs with a median of two positive nodes per patient (range 1-6). These PET/CT-positive nodes were seen in the following 16 regions: right external iliac (17) , left external iliac (10), right pararectal (6), left common iliac (5), para-aortic / interaortocaval / right common iliac (3), left obturator / right internal iliac / left internal iliac / left presacral (2), precaval / right obturator / right presacral / left pararectal / inguinal (1) (Figure 1) . A total of 644 LNs were resected with a median of 17 nodes per patient (range 3-76). Ninety nodes were retroperitoneal nodes resected during RPLND in 13 patients. Five hundred forty six nodes were PSA -prostate specific antigen; HIFU -high intensity focused ultrasound; LND -lymph node dissection; ADT -androgen deprivation therapy; PLND -pelvic lymph node dissection pelvic nodes resected during PLND in 29 patients and 8 nodes were resected during inguinal dissection in one patient. One hundred thirty-seven nodes were positive at final pathology (21%) with a median of two nodes per patient (range 0-33). Thirty-six of these positive nodes were retroperitoneal (26%), while there were no positive inguinal nodes. In seven patients (23%), no positive nodes were found at final pathology.
In a region-based analysis, 31 (55%) of the PET-positive nodes were true positives (TP), while 25 (45%) were false positives (FP) (Figure 2 ). Four nodes were only seen at the time of the revision of the PET/CT scans and were not resected. As many as 106 (77%) of the histologically-positive nodes were false negatives (FN) on the PET/CT (Figure 2 ). This results in a per-region sensitivity, specificity and PPV of 23%, 95% and 55%, respectively.
In a per-patient analysis, 15 (50%) patients had TP without FP nodes, 12 (40%) had FP nodes without TP and 3 (10%) patients had both ( Table 2) .
No pathologic LNs were found in 7 patients (23%). In 17 (57%) patients, additional FN LNs were diagnosed after histological examination. Table 3 and 4 show the relative distribution of LNs according to the anatomical regions. Attention should be brought to the fact that retroperitoneal sensitivity was 14% compared to 26% in the pelvic region. Specificity was 100% in the retroperitoneal area and 95% in the pelvic area.
In addition, it is remarkable that 17 (68%) of the 25 FP LNs were situated in the external iliac regions, while the retroperitoneal nodes did not reveal any FPs. Furthermore, all seven PET-positive pararectal nodes were confirmed malignant by histology. Left renal vein 11 0 (0%) 0 (0%) 6 (55%) 5 (46%)
DISCUSSION
Para-caval 23 1 (4%) 0 (0%) 6 (26%) 16 (70%)
Pre-aortic 4 0 (0%) 0 (0%) 0 (0%) 4 (100%)
Pre-caval 1 0 (0%) 0 (0%) 0 (0%) 1 (100%)
Firstly, 11C-choline PET/CT indicated a large number of FP nodes (25 of 56 LNs, 45%). More importantly, as many as 17 (68%) of these FP LNs were seen in the left and right external iliac area and none were situated in the retroperitoneum. In a per-patient analysis, no positive nodes were found in seven (23%) of 30 patients, accounting for 12 of the 25 FP nodes. Seven of those were in the external iliac region, four in the obturator or sacral region and one in the inguinal region. FP nodes have previously been reported. Martini et al. [21] , Scattoni et al. [18] , Passoni et al. [19] and Schilling et al. [11] respectively reported 2 out of 8 (25%), 2 out of 21 (9.5%), 8 out of 46 (17%) and 3 out of 10 (30%) FP patients in a per-patient analysis. Secondly, 106 out of 137 pathologically proven LN metastasis (77%) were not seen on the preoperative 11C-choline PET/CT and thus were FN. Out of the 36 positive nodes in the retroperitoneal area 31 (86%) were FN, whereas 75 (74%) of the 101 positive LNs in the pelvic region were FN. This difference was not significant (p = 0.2, Fisher's exact test).
The most obvious reason for the high FN rate has already been described by Scattoni et al. [18] and Jilg et al. [20] . Scattoni et al. [18] reported that the mean maximum diameter of TP nodes (15.0 mm) was significantly larger than the diameter in FN nodes (6.3 mm; p = 0.0004). These findings were confirmed by Jilg et al. [20] . They measured LN diameters and infiltration depth and performed a per-lesion analysis. A gradual increase of the imaging sensitivity was reported according to the tumor infiltration depth.
Imaging sensitivity was 0.0%, 13%, 57% and 82% for a tumor infiltration depth of <2 mm, 2-3 mm, All TP, FP and FN LNs were mapped on a vascular map in Figure 2 . A brief look at the map reveals the most striking observations of this series. in multivariate analysis [28] . It should also be acknowledged that standard histopathology techniques were used, examining only one section of the lymph node histologically. Notwithstanding, our data suggest that 11C-choline PET/CT tends to underestimate the extent of the disease and is consequently not the ideal staging study in biochemical recurrent PCa. One may conclude that there is an urgent need for more accurate and sensitive imaging. Particularly, on the background of the results reported on oligometastatic directed therapies [5, 6, 29, 30, 34] . 68Ga-PSMA PET/CT is widely believed to be the most potent alternative for choline PET/CT in PCa recurrence [23, 24, 31, 33] . Morigi 
CONCLUSIONS
In conclusion, positive 11C-choline PET/CT for lymph node involvement underestimates the number of invaded nodes at salvage pelvic or retroperitoneal lymph node dissection. In addition, our observations indicated a high rate of false positive nodes, which were mainly located in the external iliac regions. These findings suggest the limitations of 11C-choline PET/CT in the staging of patients with biochemical recurrence after radically treated PCa. Novel tracers combined with developments in PET hardware might allow for more accurate detection of sites of recurrent PCa in the near future.
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The authors declare no conflicts of interest. 5-6 mm and 10-11 mm, respectively. Unfortunately, we do not have data on the diameters of the positive LNs in our series. However, these results indicate that a minimal cancer volume is required in order to be detected by 11C-choline PET/CT. One can assume that the low sensitivity of choline PET/CT for the detection of LNMs in our study is caused by the limited spatial resolution of our PET-systems (spatial resolution with a Full-Width-At-Half-Maximum (FWHM) of 6-8 mm). It is known that novel targeted radiotracers with high tumor-to-background ratios, such as 68Ga-PSMA ligands, result in superior sensitivity and specificity [22, 23] . In addition, more sensitive PET-detection systems could allow for higher spatial resolution [24] and possibly higher detection rates. Furthermore, it has been reported that the detection rates of choline PET/CT improve with increasing serum PSA concentrations [25, 26, 27] . In our series, the median PSA was relatively low at 1.5 ng/ml (range 0.22-11.4). One might argue that PSA levels lower than 1.5 ng/ml might be beyond the detection threshold. However, a sub-analysis of the 15 patients with PSA levels higher than 1.5 ng/ml (median 2.54 ng/ml) compared to the 15 other patients (median 0.77 ng/ ml) showed no significant difference in sensitivity, specificity and PPV being 25.8% vs. 20.0%, 94.0% vs. 96.4% and 48.5% vs. 65.2%, respectively. The third important observation regards the mapping of the pathologically proven LN metastasis. Recurrent nodes were present from the pararectal area up to the renal vein. It is a notable observation that 16% (22/137) of recurrent positive nodes were situated in the presacral and pararectal areas. Moreover, up to 9% of patients with high risk PCa have been described with pathologic nodes in the presacral regions after primary RP with seLND [16] . This might support the argument for a standard presacral LND at the time of primary treatment in high risk PCa patients.
The limitations of this study are its retrospective nature and its relatively small number of patients primarily and secondarily treated with different techniques (RP, EBRT, HIFU or BT, ADT). The effect of ADT on the efficacy of 11C-choline PET/CT is controversial. Hormone therapy (HT) was (p <0.05) associated with a significantly increased risk in positive choline PET/CT results in an univariate analysis performed by Giovacchini et al. However, this effect was no longer significant
